Pfizer looks to test $50, and possibly the gap around 46~ if things get really ugly. Omicron is looking really promising as granting significant immunity after infection, which should reduce demand for further vaccinations. These vaccines companies have YEARS of covid priced into their stocks... Short side is getting a bit long in the tooth for new entries, however I am still holding 2/3rds of my puts across the board for these plays.
We posted our short thesis in another thread
Comment
⋅
Target hit! $55 will be resistance - I expect it to turn and head lower. Although opening a new short from here isn't ideal
Comment
⋅
$46 GAP FILL HIT. I expect significant news to come out which will be very negative. However, technically this is very stretched and I'd much prefer a bounce before adding more shorts.